Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ITCI Intra Cellular Therapies Inc

126,50

0,30 (0,24%)

22 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Intra Cellular Therapies Charts.

Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Intra Cellular Therapies Charts.

News Intra Cellular Therapies Inc

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 13 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Montag 13 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
Montag 13 Januar 2025 (1 Woche vor) • GlobeNewswire Inc.

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
Montag 13 Januar 2025 (1 Woche vor) • Business Wire

Form 8-K - Current report
Freitag 10 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz
Freitag 10 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Montag 6 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting
Mittwoch 11 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 7 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 5 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 4 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Intra Cellular Therapies Inc News-Artikel

Vibra Energia ON

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen